4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-25-022074
GENERAL COUNSEL & CORP SEC sold 13,712 shares at $15.00 ($205,680)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-08-13 | Sale 10b5-1 | −13,712 | $15.00 | $205,680 | 19,631 | D |
| Open-market sales · 13,712 sh · avg $15.00 · $205,680 | |||||||
Loading xslF345X05/form4-08152025_080840.xml…